The Great Weight Race: Can New Contenders Navigate the Treacherous Path of Next-Gen Obesity Drugs?
The Pharmaceutical Thunderdome: Pfizer's Bold Play in the Billion-Dollar Battle for Obesity Drugs
Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s